PH-TZ2 — Overview

PH-TZ2 is a synthetic dual incretin receptor agonist that targets both the GIP (glucose‑dependent insulinotropic polypeptide) and GLP‑1 (glucagon‑like peptide‑1) receptors. Because of its dual‑agonist profile, it is frequently used in research exploring metabolic signaling, energy balance, and multi‑pathway peptide design.

Its structure and receptor selectivity make it a valuable model compound for studying how simultaneous incretin pathway activation influences metabolic regulation.

Background & Research Interest

PH-TZ2 is commonly examined in laboratory environments focused on:

• Dual GIP/GLP‑1 receptor signaling mechanisms
• Metabolic pathway modulation involving glucose regulation and energy utilization
• Structure–activity relationships of multi‑agonist peptide analogs
• Comparative receptor binding between single‑ and dual‑agonist peptides
• Peptide engineering strategies for extended activity and enhanced receptor affinity

Its ability to activate two incretin pathways simultaneously provides a unique platform for studying complex metabolic interactions.

General Characteristics

• Peptide Type: Synthetic dual GIP/GLP‑1 receptor agonist
• Mechanistic Focus: Incretin‑based metabolic signaling
• Form: Typically supplied as a lyophilized powder
• Stability: Designed for prolonged activity in research settings
• Solubility: Commonly reconstituted in sterile, research‑grade solvents
• Purity: Provided at high purity suitable for controlled laboratory research

Storage & Handling

• Store in a cool, dry environment, protected from light
• Keep vial sealed until use
• Handle using standard laboratory safety procedures

For laboratory research only. Not for human consumption.